摘要
背景:中枢神经系统(CNS)涉及有机整合。通过生物活性化合物的紧张调节可以改变新陈代谢,以防止全身性非传染性疾病(NCDs)。关于这一点,考虑到它们的氧化还原和调节特性,植物多酚被提议为亲神经化学预防剂/治疗剂。 目的:回顾多酚药理学和对非传染性疾病的潜在神经影响。 方法:首先,提出多酚化学,以及药理学,即动力学和动力学。毒理学被特别描述。然后,综述这些化合物的功能相关性,重点是代谢中枢神经系统参与调节非传染性疾病,数据最终被整合。 结果:氧化应激是非传染性疾病的主要危险因素。多酚调节不同有机体系(包括参与代谢稳态的CNS)的氧化还原生物学。多酚神经营养性是由某些药理学特性决定的,修改神经和系统病理生理学,作用于几个生物学目标。尽管如此,因为这些植物化学物质可能引发毒性效应,所以不应该不加选择地推荐。 结论:综上所述,多酚的调节作用使中枢神经系统在新陈代谢和有机结合中发挥生理作用,以预防非传染性疾病,而不会忽视风险。
关键词: 抗氧化剂,生物利用度,癌症,中枢神经系统,化学预防,类黄酮,功能性食品,新陈代谢,氧化应激,植物化学,副作用,毒性。
图形摘要
Current Drug Targets
Title:Pharmacology and Toxicology of Polyphenols with Potential As Neurotropic Agents in Non-communicable Diseases
Volume: 19 Issue: 2
关键词: 抗氧化剂,生物利用度,癌症,中枢神经系统,化学预防,类黄酮,功能性食品,新陈代谢,氧化应激,植物化学,副作用,毒性。
摘要: Background: The central nervous system (CNS) is involved in organic integration. Nervous modulation via bioactive compounds can modify metabolism in order to prevent systemic noncommunicable diseases (NCDs). Concerning this, plant polyphenols are proposed as neurotropic chemopreventive/ therapeutic agents, given their redox and regulating properties.
Objective: To review polyphenolic pharmacology and potential neurological impact on NCDs.
Method: First, polyphenolic chemistry was presented, as well as pharmacology, i.e. kinetics and dynamics. Toxicology was particularly described. Then, functional relevance of these compounds was reviewed focusing on the metabolic CNS participation to modulate NCDs, with data being finally integrated.
Results: Oxidative stress is a major risk factor for NCDs. Polyphenols regulate the redox biology of different organic systems including the CNS, which participates in metabolic homeostasis. Polyphenolic neurotropism is determined by certain pharmacological characteristics, modifying nervous and systemic physiopathology, acting on several biological targets. Nonetheless, because these phytochemicals can trigger toxic effects, they should not be recommended indiscriminately.
Conclusion: Summing up, the modulating effects of polyphenols allow for the physiological role of CNS on metabolism and organic integration to be utilized in order to prevent NCDs, without losing sight of the risks.
Export Options
About this article
Cite this article as:
Pharmacology and Toxicology of Polyphenols with Potential As Neurotropic Agents in Non-communicable Diseases, Current Drug Targets 2018; 19 (2) . https://dx.doi.org/10.2174/1389450117666161220152336
DOI https://dx.doi.org/10.2174/1389450117666161220152336 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Clinical Development of 17-Allylamino, 17-Demethoxygeldanamycin
Current Cancer Drug Targets Preclinical and Clinical Studies of Novel Breast Cancer Drugs Targeting Molecules Involved in Protein Kinase C Signaling, the Putative Metastasis-Suppressor Gene Cap43 and the Y-box Binding Protein-1
Current Medicinal Chemistry Targeting Malignancies with Disulfiram (Antabuse): Multidrug Resistance, Angiogenesis, and Proteasome
Current Cancer Drug Targets Molecular Mechanisms and Proposed Targets for Selected Anticancer Gold Compounds
Current Topics in Medicinal Chemistry Selective Cyclooxygenase-2 Inhibitors and Non-small Cell Lung Cancer
Current Medicinal Chemistry Dynamics of CD86 Expression on Allergic Inflammation - New Insights
Recent Patents on Inflammation & Allergy Drug Discovery Novel Epigenetic Targets in Lymphoproliferative Disorders
Current Cancer Drug Targets Current Prodrug Strategies for the Delivery of Nucleotides into Cells
Drug Design Reviews - Online (Discontinued) Anthrax Fusion Protein Therapy of Cancer
Current Protein & Peptide Science Editorial (Thematic Issue: Advances with microRNAs in Tumorigenesis and Cancer Therapy)
Current Pharmaceutical Design Cancer Stem Cells of Head and Neck Squamous Cell Carcinoma
Current Cancer Therapy Reviews Albumin-Based Nanodevices as Drug Carriers
Current Pharmaceutical Design Exogenous Expression of WNT7A in Leukemia-Derived Cell Lines Induces Resistance to Chemotherapeutic Agents
Anti-Cancer Agents in Medicinal Chemistry Potential Clinical Applications of the CXCR4 Antagonist Bicyclam AMD3100
Mini-Reviews in Medicinal Chemistry Role of Rap2 and its Downstream Effectors in Tumorigenesis
Anti-Cancer Agents in Medicinal Chemistry New Indications for Established Drugs: Combined Tumor-Stroma-Targeted Cancer Therapy with PPARγ Agonists, COX-2 Inhibitors, mTOR Antagonists and Metronomic Chemotherapy
Current Cancer Drug Targets Anionic Host Defence Peptides from the Plant Kingdom: Their Anticancer Activity and Mechanisms of Action
Protein & Peptide Letters The MDM2 Inhibitor Nutlins as an Innovative Therapeutic Tool for the Treatment of Haematological Malignancies
Current Pharmaceutical Design Towards an Ontology to Support Semantics Enabled Diagnostic Decision Support Systems
Current Bioinformatics Anticancer Drug Design Using Scaffolds of β-Lactams, Sulfonamides, Quinoline, Quinoxaline and Natural Products. Drugs Advances in Clinical Trials
Current Medicinal Chemistry